Spring House, PA, United States of America

Jennifer Nemeth-Seay

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Janssen Biotech, Inc.. Active years: 2020-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer Nemeth-Seay. Retrieved from https://idiyas.com/inventor/jennifer-nemeth-seay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 10.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Spring House, PA (US) (2020)
  • Fort Washington, PA (US) (2023)

Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jennifer Nemeth-Seay

Introduction

Jennifer Nemeth-Seay is a prominent inventor based in Spring House, Pennsylvania. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of two patents to her name, her work focuses on innovative solutions for medical challenges.

Latest Patents

Jennifer's latest patents include groundbreaking inventions related to antibodies that specifically bind to various targets. One of her notable patents is for Anti-CD3 antibodies and their uses. This invention encompasses antibodies that bind to CD3, PSMA, IL1RAP, CD33, and TMEFF2, as well as combinations of these targets. Additionally, her patent on Prostate Specific Membrane Antigen (PSMA) bispecific binding agents describes isolated CD3×PSMA-bispecific antigen-binding molecules. These innovations provide new avenues for targeted therapies in cancer treatment.

Career Highlights

Jennifer Nemeth-Seay is currently employed at Janssen Biotech, Inc., where she continues to advance her research in antibody development. Her work has been instrumental in creating novel therapeutic agents that have the potential to improve patient outcomes in oncology.

Collaborations

Throughout her career, Jennifer has collaborated with esteemed colleagues, including Francois Gaudet and Ronan McDaid. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…